TGA Releases Updated Fees

Australia’s Therapeutic Goods Administration released an updated summary of fees and charges. The changes, which take effect July 1, apply to evaluation fees, application fees for manufacturing licenses and export certificates, clinical trial notification fees, inspection fees for manufacturing premises and application fees for registration and listing of products on the Australian Register of Therapeutic Goods.
International Pharmaceutical Regulatory Monitor